Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M HORWITZ

Showing results (321-330 of 830) with videos related to

Pageof 83
Sort By:
Evidence-Based Practice in Child and Adolescent Mental Health|January 28, 2025
Identification of suicide risk in a pediatric psychiatric emergency setting: Comparing the Ask Suicide-screening Questions and the Kiddie-Computerized Adaptive Test-Suicide ScalePaige E Cervantes, Robert D Gibbons, Dana E M Seag, et al.
Infection and Immunity|November 24, 1999
Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's diseaseO Cohavy, G Harth, M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Does treatment duration affect outcome after radiotherapy for prostate cancer?David J D'Ambrosio, Tianyu Li, Eric M Horwitz, et al.
Cancer|May 24, 2007
Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapyPeter B Morgan, Alexandra L Hanlon, Eric M Horwitz, et al.
Blood Advances|January 24, 2019
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphomaNeha Mehta-Shah, Kimiteru Ito, Kurt Bantilan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2013
A novel method for predicting late genitourinary toxicity after prostate radiation therapy and the need for age-based risk-adapted dose constraintsAwad A Ahmed, Brian Egleston, Pino Alcantara, et al.
Annals of Internal Medicine|March 29, 2020
A War on Two Fronts: Cancer Care in the Time of COVID-19Alexander Kutikov, David S Weinberg, Martin J Edelman, et al.
RSC Chemical Biology|April 20, 2022
Structural insights into inhibition of the drug target dihydroorotate dehydrogenase by bacterial hydroxyalkylquinolinesSamantha M Horwitz, Tamra C Blue, Joseph A Ambarian, et al.
Journal of the National Cancer Institute|April 5, 2017
Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate CancerAlan Pollack, Deukwoo Kwon, Gail Walker, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046Mark K Buyyounouski, Alexandra L Hanlon, Robert A Price, et al.
Pageof 83

Showing results (321-330 of 830) with videos related to

Sort By:
Pageof 83
Evidence-Based Practice in Child and Adolescent Mental Health|January 28, 2025
Identification of suicide risk in a pediatric psychiatric emergency setting: Comparing the Ask Suicide-screening Questions and the Kiddie-Computerized Adaptive Test-Suicide ScalePaige E Cervantes, Robert D Gibbons, Dana E M Seag, et al.
Infection and Immunity|November 24, 1999
Identification of a novel mycobacterial histone H1 homologue (HupB) as an antigenic target of pANCA monoclonal antibody and serum immunoglobulin A from patients with Crohn's diseaseO Cohavy, G Harth, M Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|May 13, 2008
Does treatment duration affect outcome after radiotherapy for prostate cancer?David J D'Ambrosio, Tianyu Li, Eric M Horwitz, et al.
Cancer|May 24, 2007
Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapyPeter B Morgan, Alexandra L Hanlon, Eric M Horwitz, et al.
Blood Advances|January 24, 2019
Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphomaNeha Mehta-Shah, Kimiteru Ito, Kurt Bantilan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 14, 2013
A novel method for predicting late genitourinary toxicity after prostate radiation therapy and the need for age-based risk-adapted dose constraintsAwad A Ahmed, Brian Egleston, Pino Alcantara, et al.
Annals of Internal Medicine|March 29, 2020
A War on Two Fronts: Cancer Care in the Time of COVID-19Alexander Kutikov, David S Weinberg, Martin J Edelman, et al.
RSC Chemical Biology|April 20, 2022
Structural insights into inhibition of the drug target dihydroorotate dehydrogenase by bacterial hydroxyalkylquinolinesSamantha M Horwitz, Tamra C Blue, Joseph A Ambarian, et al.
Journal of the National Cancer Institute|April 5, 2017
Prospective Validation of Diagnostic Tumor Biomarkers in Men Treated With Radiotherapy for Prostate CancerAlan Pollack, Deukwoo Kwon, Gail Walker, et al.
International Journal of Radiation Oncology, Biology, Physics|December 14, 2004
In regard to Selek et al. erectile dysfunction and radiation dose to penile base structures: a lack of correlation. IJROBP 2004;59:1039-1046Mark K Buyyounouski, Alexandra L Hanlon, Robert A Price, et al.
Pageof 83